Benzinga
05 Dec 2025, 18:10 UTC · 45w ago
Verdict
Headline takes no side. We score PRAX +0.90 — strongly bullish.
+0.90strongly bullish
More positive than 97% of ticker scores this week
Scored by the NIS engine · methodology.
Which stocks this story touches
More positive than 97% of ticker scores this week
The company's epilepsy drug study was stopped early for efficacy, leading to a price target increase and a 30% surge in share price.
Continue reading
5 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
7h ago
+35.0%
Price agrees with the score
$256.47 vs $189.97 close before publication (Dec 4) · not market-adjusted
PRAX chart →
